Bundamedik Tbk PT (BMHS) — Cash Flow Reinvestment Rate
Bundamedik Tbk PT (BMHS) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Rp116.26 Billion (capex Rp116.26 Billion ) from operating cash flow of Rp199.64 Billion. Explore BMHS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bundamedik Tbk PT Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Bundamedik Tbk PT across 8 annual periods. Also explore BMHS total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bundamedik Tbk PT (2018–2025)
Year-by-year capital reinvestment analysis for Bundamedik Tbk PT. For live market cap and broader valuation context, see BMHS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | Rp218.91 Billion | Rp250.62 Billion | Rp218.91 Billion | ▼ -93.8% |
| 2024 | 14.16x | Rp481.32 Billion | Rp33.98 Billion | Rp236.03 Billion | ▲ +72.8% |
| 2023 | 8.20x | Rp421.57 Billion | Rp51.44 Billion | Rp209.35 Billion | ▲ +163.1% |
| 2022 | 3.12x | Rp739.76 Billion | Rp237.47 Billion | Rp301.73 Billion | ▲ +336.2% |
| 2021 | 0.71x | Rp249.57 Billion | Rp349.44 Billion | Rp228.08 Billion | ▲ +91.2% |
| 2020 | 0.37x | Rp71.10 Billion | Rp190.36 Billion | Rp49.61 Billion | ▼ -60.2% |
| 2019 | 0.94x | Rp84.26 Billion | Rp89.72 Billion | Rp72.50 Billion | ▼ -73.7% |
| 2018 | 3.57x | Rp156.54 Billion | Rp43.79 Billion | Rp156.54 Billion | — |